Currently, most therapeutic and preventative measures for AD are largely ineffective, with the presently utilized therapies centralizing on cholinesterase inhibitor activity, encompassing donepezil, rivastigmine, and galantamine, or suppressing ionotropic glutamatergic signals by memantine [193,194]. This evidence concerns the gene BCHE and Alzheimer disease.